| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/20/2009 | WO2009102318A1 Hepatitis c virus inhibitors |
| 08/20/2009 | WO2009102240A2 Medicinal agent for treating oncological diseases |
| 08/20/2009 | WO2009102226A1 Malonic acid salt of 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- 2,4-thiazolidinedione |
| 08/20/2009 | WO2009102199A1 A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants |
| 08/20/2009 | WO2009102193A1 A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants |
| 08/20/2009 | WO2009102179A2 Apoptosis inducer composition for hormone-sensitive prostatic cancer cells |
| 08/20/2009 | WO2009102083A1 Novel clitocybin derivatives, preparation method thereof and composition containing the extract of clitocybe aurantiaca kctc 11143bp or the novel clitocybin derivatives for prevention of aging as an active ingredient |
| 08/20/2009 | WO2009102081A1 Cyclic single-stranded nucleic acid complex and method for producing the same |
| 08/20/2009 | WO2009102038A1 Orally disintegrating tablets |
| 08/20/2009 | WO2009101967A1 Phosphatidylserine complex and method for stabilization of phosphatidylserine |
| 08/20/2009 | WO2009101959A1 Novel compound, lachnochromonin compound |
| 08/20/2009 | WO2009101956A1 Novel substance fki-3864 and method for production thereof |
| 08/20/2009 | WO2009101940A1 Tablet having improved elution properties |
| 08/20/2009 | WO2009101917A1 Bicycloamine derivative |
| 08/20/2009 | WO2009101812A1 Glutamic acid transporter inhibitor |
| 08/20/2009 | WO2009101698A1 Composition and method for suppressing fat accumulation |
| 08/20/2009 | WO2009101684A1 Drug for preventing and/or treating visceral fusion |
| 08/20/2009 | WO2009101616A1 Novel conjugates for treating neurodegenerative diseases and disorders |
| 08/20/2009 | WO2009101614A1 Casein particles encapsulating therapeutically active agents and uses thereof |
| 08/20/2009 | WO2009101497A2 Topical pharmaceutical combination comprising minoxidil and aminexil |
| 08/20/2009 | WO2009101475A2 Use of glycosylceramides for enhancing the immune response to antigens |
| 08/20/2009 | WO2009101458A2 New polymorph and amorphous forms of desvenlafaxine fumarate |
| 08/20/2009 | WO2009101412A1 Topical pharmaceutical composition |
| 08/20/2009 | WO2009101399A1 Treatment of muscular dystrophy using peptide nucleic acid ( pna) |
| 08/20/2009 | WO2009101345A1 Novel anti-infectious derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment |
| 08/20/2009 | WO2009101258A1 Novel pharmaceutical formulation |
| 08/20/2009 | WO2009101210A1 Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases |
| 08/20/2009 | WO2009101199A2 Treatment of acne vulgaris; rosacea and rhinophym |
| 08/20/2009 | WO2009101194A1 Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases |
| 08/20/2009 | WO2009101182A1 Use of etonogestrel for benign prostate hyperplasia (bph). |
| 08/20/2009 | WO2009101137A1 Use of 25-hydroxy-vitamin d3 to affect human muscle physiology |
| 08/20/2009 | WO2009101136A1 Treating hyperglycemia with 25-hydroxyvitamin d3 |
| 08/20/2009 | WO2009101135A1 Combined use of 25-hydroxy-vitamin d3 and vitamin d3 for improving bone mineral density and for treating osteoporosis |
| 08/20/2009 | WO2009101132A1 Combination of vitamin d and 25-hydroxyvitamin d 3 |
| 08/20/2009 | WO2009101131A1 Treating hypertension with 25-hydroxyvitamin d3 |
| 08/20/2009 | WO2009101022A1 Heterocyclic antiviral compounds |
| 08/20/2009 | WO2009101021A2 Estradiol-containing drug delivery system |
| 08/20/2009 | WO2009101018A2 3-alkyl-piperazine derivatives and uses thereof |
| 08/20/2009 | WO2009100994A1 Piperidine sulfonamide derivatives |
| 08/20/2009 | WO2009100955A1 Antisense rna targeting cxcr4 |
| 08/20/2009 | WO2009100949A1 Zwitterionic guanidinium compounds as selective antimicrobial active ingredients |
| 08/20/2009 | WO2009100936A2 Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds, and the use thereof |
| 08/20/2009 | WO2009100929A1 Pharmaceutical compositions comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2- dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide |
| 08/20/2009 | WO2009100890A1 Products made of o-acylated hydroxycarboxylic acids and amino acids, the production, biological activities, cosmetically or pharmaceutically effective compositions and use thereof, particularly as food additives, and as cosmetic additives |
| 08/20/2009 | WO2009100886A2 Formulations of flibanserin |
| 08/20/2009 | WO2009100872A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/20/2009 | WO2009100871A2 Drug delivery system with stabilising effect |
| 08/20/2009 | WO2009100827A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof |
| 08/20/2009 | WO2009100723A2 Crystalline forms of an antibiotic substance |
| 08/20/2009 | WO2009100716A2 Implantable products comprising nanoparticles |
| 08/20/2009 | WO2009100691A1 Polymorphic form ( iii ) of the adamantylamino- platinum (iv) complex la- 12 |
| 08/20/2009 | WO2009100690A1 Amourphous form of the adamantylamino-platinum ( iv) complexla-12 |
| 08/20/2009 | WO2009100689A1 Polymorphic form ( ii ) of adamantylamino- platinum ( iv) complex la-12 |
| 08/20/2009 | WO2009100688A1 Polymorphic form ( i ) of the adamantylamino-platinum (iv) complex la-12 |
| 08/20/2009 | WO2009100656A1 2-methylene-5-substituted methylene cyclopentanone derivatives and use thereof |
| 08/20/2009 | WO2009100655A1 The aromatic ring triazine derivatives and the uses thereof |
| 08/20/2009 | WO2009100592A1 Preparation of rupatadine or it's salts |
| 08/20/2009 | WO2009100587A1 A drug composition for treatment and prevention of ischemic stroke and its preparation methods |
| 08/20/2009 | WO2009100536A1 Inhibitors of kinase activity with 1,2-di-cyclyl substituted alkyne structures |
| 08/20/2009 | WO2009100534A1 Combination therapy to treat vascular disorders |
| 08/20/2009 | WO2009100532A1 NOVEL 17ß LUPANE DERIVATIVES |
| 08/20/2009 | WO2009100502A1 Immunostimulatory sirna molecules |
| 08/20/2009 | WO2009082268A3 LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF |
| 08/20/2009 | WO2009081283A3 Aqueous formulations of acetaminophen for injection |
| 08/20/2009 | WO2009081105A3 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 08/20/2009 | WO2009079775A9 Composition for supporting heat shock protein function comprising glutamine |
| 08/20/2009 | WO2009079412A3 Reverse transcriptase inhibitors |
| 08/20/2009 | WO2009077068A9 Ester derivatives as phosphodiesterase inhibitors |
| 08/20/2009 | WO2009074749A3 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 08/20/2009 | WO2009074733A3 Addition salts of angiotensine-converting enzyme inhibitors with no donor acids, method for preparing same and pharmaceutical compositions containing same |
| 08/20/2009 | WO2009073527A3 Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases |
| 08/20/2009 | WO2009072808A3 Cosmetic composition for body slimming containing 2-cyclopentene-1-one oxime derivatives |
| 08/20/2009 | WO2009071905A3 Use of thiolatocobalamins as regulators/selective promoters of inducible and constitutive nitric oxide synthases |
| 08/20/2009 | WO2009071668A3 Piperazine derivatives and their use as leptin receptor modulators |
| 08/20/2009 | WO2009069966A3 Use of compounds for controlling the function of sphingosylphosphorylcholine |
| 08/20/2009 | WO2009068246A3 Methods of treating obesity and metabolic disorders |
| 08/20/2009 | WO2009068214A3 Heteroaryl-substituted piperidines |
| 08/20/2009 | WO2009067699A3 Methods for providing a system of care for an oxazaphosphorine drug regimen |
| 08/20/2009 | WO2009066181A3 Oral delayed-release duloxentine hydrochloride pellets |
| 08/20/2009 | WO2009065596A3 Use of mnk inhibitors for the treatment of alzheimer's disease |
| 08/20/2009 | WO2009059050A3 Tlr modulators and methods for using the same |
| 08/20/2009 | WO2009059048A3 (+)-opioids and methods of use |
| 08/20/2009 | WO2009053654A3 Gemcitabine phosphoester prodrugs as anticancer agents |
| 08/20/2009 | WO2009053604A3 Influenza virus haemagglutinin-specific monoclonal antibodies |
| 08/20/2009 | WO2009047296A3 Metabotropic glutamate receptor modulators for the treatment op parkinson's disease |
| 08/20/2009 | WO2009043889A3 Oxadiazole derivatives |
| 08/20/2009 | WO2009043354A3 Combination treatment for the treatment of hepatitis c virus infection |
| 08/20/2009 | WO2009043353A3 Micromirs |
| 08/20/2009 | WO2009040373A3 Galenical formulations of aliskiren |
| 08/20/2009 | WO2009038673A3 Thieno-and furo-pyrimidine modulators of the histamine h4 receptor |
| 08/20/2009 | WO2009033078A3 Compositions and methods for controlling cholesterol levels |
| 08/20/2009 | WO2009025876A3 Crystalline forms of erlotinib hcl and formulations thereof |
| 08/20/2009 | WO2009025791A3 Purification of armodafinil |
| 08/20/2009 | WO2009004484A3 Trim24 (tifla) as p53 modulator and cancer target |
| 08/20/2009 | WO2009004146A3 Novel herbimycin a analogue derivatives, compositions containing same and use thereof |
| 08/20/2009 | WO2008148873A3 Hydroxyproline compositions and uses thereof |
| 08/20/2009 | WO2008145365A3 Treatment of surfactants with cyclodextrins |
| 08/20/2009 | WO2008139261A3 Omega-3 lipid compound |
| 08/20/2009 | WO2008136000A3 Compositions, articles and methods for preventing or reducing tobacco-associated damage |
| 08/20/2009 | WO2008129468A3 Pharmaceutical compositions of clopidogrel |